DEBORAH SMITH: Open Payments
NPI 1912316613 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 24 payments from 14 companies in 2025. Trend: 2023 $451 · 2024 $1,807 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $101 |
| Celgene Corporation | 3 | $61 |
| Genentech USA, Inc. | 3 | $60 |
| Spectrum Pharmaceuticals Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| TerSera Therapeutics LLC | 1 | $22 |
| SOBI, INC | 1 | $21 |
| Aveo Pharmaceuticals, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: IBRANCE, REBLOZYL, Itovebi, ROLVEDON, OPDIVO, Zoladex, Doptelet, FOTIVDA.
Industry payments across LA — which companies pay providers there.
